Global Post Herpetic Neuralgia Therapies Market Growth (Status and Outlook) 2025-2031

September 2025 | 89 pages | ID: GE0528FB6AFEN
LP Information

Abstracts

According to this study, the global Post Herpetic Neuralgia Therapies market size will reach US$ 2204 million by 2031.

Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for postherpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Post Herpetic Neuralgia Therapies Industry Forecast” looks at past sales and reviews total world Post Herpetic Neuralgia Therapies sales in 2024, providing a comprehensive analysis by region and market sector of projected Post Herpetic Neuralgia Therapies sales for 2025 through 2031. With Post Herpetic Neuralgia Therapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Post Herpetic Neuralgia Therapies industry.

This Insight Report provides a comprehensive analysis of the global Post Herpetic Neuralgia Therapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Post Herpetic Neuralgia Therapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Post Herpetic Neuralgia Therapies market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Post Herpetic Neuralgia Therapies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Post Herpetic Neuralgia Therapies.

This report presents a comprehensive overview, market shares, and growth opportunities of Post Herpetic Neuralgia Therapies market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Drugs
• Patches
• Steroid Injectable

Segmentation by Application:

• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Endo Pharmaceuticals
• Depomed
• Acorda Therapeutics
• Pfizer
• Mylan
• Daiichi Sankyo
• Teikoku Pharma

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Post Herpetic Neuralgia Therapies Market Size (2020-2031)
  2.1.2 Post Herpetic Neuralgia Therapies Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Post Herpetic Neuralgia Therapies by Country/Region (2020, 2024 & 2031)
2.2 Post Herpetic Neuralgia Therapies Segment by Type
  2.2.1 Drugs
  2.2.2 Patches
  2.2.3 Steroid Injectable
2.3 Post Herpetic Neuralgia Therapies Market Size by Type
  2.3.1 Post Herpetic Neuralgia Therapies Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Post Herpetic Neuralgia Therapies Market Size Market Share by Type (2020-2025)
2.4 Post Herpetic Neuralgia Therapies Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Online Pharmacies
  2.4.3 Retail Pharmacies
2.5 Post Herpetic Neuralgia Therapies Market Size by Application
  2.5.1 Post Herpetic Neuralgia Therapies Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Post Herpetic Neuralgia Therapies Market Size Market Share by Application (2020-2025)

3 POST HERPETIC NEURALGIA THERAPIES MARKET SIZE BY PLAYER

3.1 Post Herpetic Neuralgia Therapies Market Size Market Share by Player
  3.1.1 Global Post Herpetic Neuralgia Therapies Revenue by Player (2020-2025)
  3.1.2 Global Post Herpetic Neuralgia Therapies Revenue Market Share by Player (2020-2025)
3.2 Global Post Herpetic Neuralgia Therapies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 POST HERPETIC NEURALGIA THERAPIES BY REGION

4.1 Post Herpetic Neuralgia Therapies Market Size by Region (2020-2025)
4.2 Global Post Herpetic Neuralgia Therapies Annual Revenue by Country/Region (2020-2025)
4.3 Americas Post Herpetic Neuralgia Therapies Market Size Growth (2020-2025)
4.4 APAC Post Herpetic Neuralgia Therapies Market Size Growth (2020-2025)
4.5 Europe Post Herpetic Neuralgia Therapies Market Size Growth (2020-2025)
4.6 Middle East & Africa Post Herpetic Neuralgia Therapies Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Post Herpetic Neuralgia Therapies Market Size by Country (2020-2025)
5.2 Americas Post Herpetic Neuralgia Therapies Market Size by Type (2020-2025)
5.3 Americas Post Herpetic Neuralgia Therapies Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Post Herpetic Neuralgia Therapies Market Size by Region (2020-2025)
6.2 APAC Post Herpetic Neuralgia Therapies Market Size by Type (2020-2025)
6.3 APAC Post Herpetic Neuralgia Therapies Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Post Herpetic Neuralgia Therapies Market Size by Country (2020-2025)
7.2 Europe Post Herpetic Neuralgia Therapies Market Size by Type (2020-2025)
7.3 Europe Post Herpetic Neuralgia Therapies Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Post Herpetic Neuralgia Therapies by Region (2020-2025)
8.2 Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Type (2020-2025)
8.3 Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL POST HERPETIC NEURALGIA THERAPIES MARKET FORECAST

10.1 Global Post Herpetic Neuralgia Therapies Forecast by Region (2026-2031)
  10.1.1 Global Post Herpetic Neuralgia Therapies Forecast by Region (2026-2031)
  10.1.2 Americas Post Herpetic Neuralgia Therapies Forecast
  10.1.3 APAC Post Herpetic Neuralgia Therapies Forecast
  10.1.4 Europe Post Herpetic Neuralgia Therapies Forecast
  10.1.5 Middle East & Africa Post Herpetic Neuralgia Therapies Forecast
10.2 Americas Post Herpetic Neuralgia Therapies Forecast by Country (2026-2031)
  10.2.1 United States Market Post Herpetic Neuralgia Therapies Forecast
  10.2.2 Canada Market Post Herpetic Neuralgia Therapies Forecast
  10.2.3 Mexico Market Post Herpetic Neuralgia Therapies Forecast
  10.2.4 Brazil Market Post Herpetic Neuralgia Therapies Forecast
10.3 APAC Post Herpetic Neuralgia Therapies Forecast by Region (2026-2031)
  10.3.1 China Post Herpetic Neuralgia Therapies Market Forecast
  10.3.2 Japan Market Post Herpetic Neuralgia Therapies Forecast
  10.3.3 Korea Market Post Herpetic Neuralgia Therapies Forecast
  10.3.4 Southeast Asia Market Post Herpetic Neuralgia Therapies Forecast
  10.3.5 India Market Post Herpetic Neuralgia Therapies Forecast
  10.3.6 Australia Market Post Herpetic Neuralgia Therapies Forecast
10.4 Europe Post Herpetic Neuralgia Therapies Forecast by Country (2026-2031)
  10.4.1 Germany Market Post Herpetic Neuralgia Therapies Forecast
  10.4.2 France Market Post Herpetic Neuralgia Therapies Forecast
  10.4.3 UK Market Post Herpetic Neuralgia Therapies Forecast
  10.4.4 Italy Market Post Herpetic Neuralgia Therapies Forecast
  10.4.5 Russia Market Post Herpetic Neuralgia Therapies Forecast
10.5 Middle East & Africa Post Herpetic Neuralgia Therapies Forecast by Region (2026-2031)
  10.5.1 Egypt Market Post Herpetic Neuralgia Therapies Forecast
  10.5.2 South Africa Market Post Herpetic Neuralgia Therapies Forecast
  10.5.3 Israel Market Post Herpetic Neuralgia Therapies Forecast
  10.5.4 Turkey Market Post Herpetic Neuralgia Therapies Forecast
10.6 Global Post Herpetic Neuralgia Therapies Forecast by Type (2026-2031)
10.7 Global Post Herpetic Neuralgia Therapies Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Post Herpetic Neuralgia Therapies Forecast

11 KEY PLAYERS ANALYSIS

11.1 Endo Pharmaceuticals
  11.1.1 Endo Pharmaceuticals Company Information
  11.1.2 Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Product Offered
  11.1.3 Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Endo Pharmaceuticals Main Business Overview
  11.1.5 Endo Pharmaceuticals Latest Developments
11.2 Depomed
  11.2.1 Depomed Company Information
  11.2.2 Depomed Post Herpetic Neuralgia Therapies Product Offered
  11.2.3 Depomed Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Depomed Main Business Overview
  11.2.5 Depomed Latest Developments
11.3 Acorda Therapeutics
  11.3.1 Acorda Therapeutics Company Information
  11.3.2 Acorda Therapeutics Post Herpetic Neuralgia Therapies Product Offered
  11.3.3 Acorda Therapeutics Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Acorda Therapeutics Main Business Overview
  11.3.5 Acorda Therapeutics Latest Developments
11.4 Pfizer
  11.4.1 Pfizer Company Information
  11.4.2 Pfizer Post Herpetic Neuralgia Therapies Product Offered
  11.4.3 Pfizer Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Pfizer Main Business Overview
  11.4.5 Pfizer Latest Developments
11.5 Mylan
  11.5.1 Mylan Company Information
  11.5.2 Mylan Post Herpetic Neuralgia Therapies Product Offered
  11.5.3 Mylan Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Mylan Main Business Overview
  11.5.5 Mylan Latest Developments
11.6 Daiichi Sankyo
  11.6.1 Daiichi Sankyo Company Information
  11.6.2 Daiichi Sankyo Post Herpetic Neuralgia Therapies Product Offered
  11.6.3 Daiichi Sankyo Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Daiichi Sankyo Main Business Overview
  11.6.5 Daiichi Sankyo Latest Developments
11.7 Teikoku Pharma
  11.7.1 Teikoku Pharma Company Information
  11.7.2 Teikoku Pharma Post Herpetic Neuralgia Therapies Product Offered
  11.7.3 Teikoku Pharma Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Teikoku Pharma Main Business Overview
  11.7.5 Teikoku Pharma Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Post Herpetic Neuralgia Therapies Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Post Herpetic Neuralgia Therapies Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Drugs
Table 4. Major Players of Patches
Table 5. Major Players of Steroid Injectable
Table 6. Post Herpetic Neuralgia Therapies Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Post Herpetic Neuralgia Therapies Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Post Herpetic Neuralgia Therapies Market Size Market Share by Type (2020-2025)
Table 9. Post Herpetic Neuralgia Therapies Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Post Herpetic Neuralgia Therapies Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Post Herpetic Neuralgia Therapies Market Size Market Share by Application (2020-2025)
Table 12. Global Post Herpetic Neuralgia Therapies Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Post Herpetic Neuralgia Therapies Revenue Market Share by Player (2020-2025)
Table 14. Post Herpetic Neuralgia Therapies Key Players Head office and Products Offered
Table 15. Post Herpetic Neuralgia Therapies Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Post Herpetic Neuralgia Therapies Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Post Herpetic Neuralgia Therapies Market Size Market Share by Region (2020-2025)
Table 20. Global Post Herpetic Neuralgia Therapies Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Post Herpetic Neuralgia Therapies Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Post Herpetic Neuralgia Therapies Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Post Herpetic Neuralgia Therapies Market Size Market Share by Country (2020-2025)
Table 24. Americas Post Herpetic Neuralgia Therapies Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Post Herpetic Neuralgia Therapies Market Size Market Share by Type (2020-2025)
Table 26. Americas Post Herpetic Neuralgia Therapies Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Post Herpetic Neuralgia Therapies Market Size Market Share by Application (2020-2025)
Table 28. APAC Post Herpetic Neuralgia Therapies Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Post Herpetic Neuralgia Therapies Market Size Market Share by Region (2020-2025)
Table 30. APAC Post Herpetic Neuralgia Therapies Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Post Herpetic Neuralgia Therapies Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Post Herpetic Neuralgia Therapies Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Post Herpetic Neuralgia Therapies Market Size Market Share by Country (2020-2025)
Table 34. Europe Post Herpetic Neuralgia Therapies Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Post Herpetic Neuralgia Therapies Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Post Herpetic Neuralgia Therapies
Table 40. Key Market Challenges & Risks of Post Herpetic Neuralgia Therapies
Table 41. Key Industry Trends of Post Herpetic Neuralgia Therapies
Table 42. Global Post Herpetic Neuralgia Therapies Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Post Herpetic Neuralgia Therapies Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Post Herpetic Neuralgia Therapies Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Post Herpetic Neuralgia Therapies Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Endo Pharmaceuticals Details, Company Type, Post Herpetic Neuralgia Therapies Area Served and Its Competitors
Table 47. Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Product Offered
Table 48. Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Endo Pharmaceuticals Main Business
Table 50. Endo Pharmaceuticals Latest Developments
Table 51. Depomed Details, Company Type, Post Herpetic Neuralgia Therapies Area Served and Its Competitors
Table 52. Depomed Post Herpetic Neuralgia Therapies Product Offered
Table 53. Depomed Post Herpetic Neuralgia Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Depomed Main Business
Table 55. Depomed Latest Developments
Table 56. Acorda Therapeutics Details, Company Type, Post Herpetic Neuralgia Therapies Area Served and Its Competitors
Table 57. Acorda Therapeutics Post Herpetic Neuralgia Therapies Product Offered
Table 58. Acorda Therapeutics Post Herpetic Neuralgia Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Acorda Therapeutics Main Business
Table 60. Acorda Therapeutics Latest Developments
Table 61. Pfizer Details, Company Type, Post Herpetic Neuralgia Therapies Area Served and Its Competitors
Table 62. Pfizer Post Herpetic Neuralgia Therapies Product Offered
Table 63. Pfizer Post Herpetic Neuralgia Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Pfizer Main Business
Table 65. Pfizer Latest Developments
Table 66. Mylan Details, Company Type, Post Herpetic Neuralgia Therapies Area Served and Its Competitors
Table 67. Mylan Post Herpetic Neuralgia Therapies Product Offered
Table 68. Mylan Post Herpetic Neuralgia Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Mylan Main Business
Table 70. Mylan Latest Developments
Table 71. Daiichi Sankyo Details, Company Type, Post Herpetic Neuralgia Therapies Area Served and Its Competitors
Table 72. Daiichi Sankyo Post Herpetic Neuralgia Therapies Product Offered
Table 73. Daiichi Sankyo Post Herpetic Neuralgia Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Daiichi Sankyo Main Business
Table 75. Daiichi Sankyo Latest Developments
Table 76. Teikoku Pharma Details, Company Type, Post Herpetic Neuralgia Therapies Area Served and Its Competitors
Table 77. Teikoku Pharma Post Herpetic Neuralgia Therapies Product Offered
Table 78. Teikoku Pharma Post Herpetic Neuralgia Therapies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Teikoku Pharma Main Business
Table 80. Teikoku Pharma Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Post Herpetic Neuralgia Therapies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Post Herpetic Neuralgia Therapies Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Post Herpetic Neuralgia Therapies Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Post Herpetic Neuralgia Therapies Sales Market Share by Country/Region (2024)
Figure 8. Post Herpetic Neuralgia Therapies Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Post Herpetic Neuralgia Therapies Market Size Market Share by Type in 2024
Figure 10. Post Herpetic Neuralgia Therapies in Hospital Pharmacies
Figure 11. Global Post Herpetic Neuralgia Therapies Market: Hospital Pharmacies (2020-2025) & ($ millions)
Figure 12. Post Herpetic Neuralgia Therapies in Online Pharmacies
Figure 13. Global Post Herpetic Neuralgia Therapies Market: Online Pharmacies (2020-2025) & ($ millions)
Figure 14. Post Herpetic Neuralgia Therapies in Retail Pharmacies
Figure 15. Global Post Herpetic Neuralgia Therapies Market: Retail Pharmacies (2020-2025) & ($ millions)
Figure 16. Global Post Herpetic Neuralgia Therapies Market Size Market Share by Application in 2024
Figure 17. Global Post Herpetic Neuralgia Therapies Revenue Market Share by Player in 2024
Figure 18. Global Post Herpetic Neuralgia Therapies Market Size Market Share by Region (2020-2025)
Figure 19. Americas Post Herpetic Neuralgia Therapies Market Size 2020-2025 ($ millions)
Figure 20. APAC Post Herpetic Neuralgia Therapies Market Size 2020-2025 ($ millions)
Figure 21. Europe Post Herpetic Neuralgia Therapies Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size 2020-2025 ($ millions)
Figure 23. Americas Post Herpetic Neuralgia Therapies Value Market Share by Country in 2024
Figure 24. United States Post Herpetic Neuralgia Therapies Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Post Herpetic Neuralgia Therapies Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Post Herpetic Neuralgia Therapies Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Post Herpetic Neuralgia Therapies Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Post Herpetic Neuralgia Therapies Market Size Market Share by Region in 2024
Figure 29. APAC Post Herpetic Neuralgia Therapies Market Size Market Share by Type (2020-2025)
Figure 30. APAC Post Herpetic Neuralgia Therapies Market Size Market Share by Application (2020-2025)
Figure 31. China Post Herpetic Neuralgia Therapies Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Post Herpetic Neuralgia Therapies Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Post Herpetic Neuralgia Therapies Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Post Herpetic Neuralgia Therapies Market Size Growth 2020-2025 ($ millions)
Figure 35. India Post Herpetic Neuralgia Therapies Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Post Herpetic Neuralgia Therapies Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Post Herpetic Neuralgia Therapies Market Size Market Share by Country in 2024
Figure 38. Europe Post Herpetic Neuralgia Therapies Market Size Market Share by Type (2020-2025)
Figure 39. Europe Post Herpetic Neuralgia Therapies Market Size Market Share by Application (2020-2025)
Figure 40. Germany Post Herpetic Neuralgia Therapies Market Size Growth 2020-2025 ($ millions)
Figure 41. France Post Herpetic Neuralgia Therapies Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Post Herpetic Neuralgia Therapies Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Post Herpetic Neuralgia Therapies Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Post Herpetic Neuralgia Therapies Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Post Herpetic Neuralgia Therapies Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Post Herpetic Neuralgia Therapies Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Post Herpetic Neuralgia Therapies Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Post Herpetic Neuralgia Therapies Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Post Herpetic Neuralgia Therapies Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Post Herpetic Neuralgia Therapies Market Size 2026-2031 ($ millions)
Figure 54. APAC Post Herpetic Neuralgia Therapies Market Size 2026-2031 ($ millions)
Figure 55. Europe Post Herpetic Neuralgia Therapies Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size 2026-2031 ($ millions)
Figure 57. United States Post Herpetic Neuralgia Therapies Market Size 2026-2031 ($ millions)
Figure 58. Canada Post Herpetic Neuralgia Therapies Market Size 2026-2031 ($ millions)
Figure 59. Mexico Post Herpetic Neuralgia Therapies Market Size 2026-2031 ($ millions)
Figure 60. Brazil Post Herpetic Neuralgia Therapies Market Size 2026-2031 ($ millions)
Figure 61. China Post Herpetic Neuralgia Therapies Market Size 2026-2031 ($ millions)
Figure 62. Japan Post Herpetic Neuralgia Therapies Market Size 2026-2031 ($ millions)
Figure 63. Korea Post Herpetic Neuralgia Therapies Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Post Herpetic Neuralgia Therapies Market Size 2026-2031 ($ millions)
Figure 65. India Post Herpetic Neuralgia Therapies Market Size 2026-2031 ($ millions)
Figure 66. Australia Post Herpetic Neuralgia Therapies Market Size 2026-2031 ($ millions)
Figure 67. Germany Post Herpetic Neuralgia Therapies Market Size 2026-2031 ($ millions)
Figure 68. France Post Herpetic Neuralgia Therapies Market Size 2026-2031 ($ millions)
Figure 69. UK Post Herpetic Neuralgia Therapies Market Size 2026-2031 ($ millions)
Figure 70. Italy Post Herpetic Neuralgia Therapies Market Size 2026-2031 ($ millions)
Figure 71. Russia Post Herpetic Neuralgia Therapies Market Size 2026-2031 ($ millions)
Figure 72. Egypt Post Herpetic Neuralgia Therapies Market Size 2026-2031 ($ millions)
Figure 73. South Africa Post Herpetic Neuralgia Therapies Market Size 2026-2031 ($ millions)
Figure 74. Israel Post Herpetic Neuralgia Therapies Market Size 2026-2031 ($ millions)
Figure 75. Turkey Post Herpetic Neuralgia Therapies Market Size 2026-2031 ($ millions)
Figure 76. Global Post Herpetic Neuralgia Therapies Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Post Herpetic Neuralgia Therapies Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Post Herpetic Neuralgia Therapies Market Size 2026-2031 ($ millions)